Open AccessHIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine
Author(s) -
Gillian Hunt,
Ashraf Coovadia,
Elaine J. Abrams,
Gayle Sherman,
Tammy Meyers,
Lynn Morris,
Louise Kuhn
Publication year - 2011
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e3283492180
Subject(s) - nevirapine , regimen , medicine , genotyping , population , drug resistance , virology , viral load , ritonavir , etravirine , oncology , biology , genotype , human immunodeficiency virus (hiv) , antiretroviral therapy , genetics , environmental health , gene
To describe the prevalence of HIV-1 drug resistance mutations at the time of treatment initiation in a large cohort of HIV-infected children previously exposed to single-dose nevirapine (sdNVP) for prevention of transmission.